244 related articles for article (PubMed ID: 20601024)
1. Regulatory acceptability of the minipig in the development of pharmaceuticals, chemicals and other products.
van der Laan JW; Brightwell J; McAnulty P; Ratky J; Stark C;
J Pharmacol Toxicol Methods; 2010; 62(3):184-95. PubMed ID: 20601024
[TBL] [Abstract][Full Text] [Related]
2. The RETHINK project on minipigs in the toxicity testing of new medicines and chemicals: conclusions and recommendations.
Forster R; Bode G; Ellegaard L; van der Laan JW
J Pharmacol Toxicol Methods; 2010; 62(3):236-42. PubMed ID: 20685309
[TBL] [Abstract][Full Text] [Related]
3. The RETHINK project--minipigs as models for the toxicity testing of new medicines and chemicals: an impact assessment.
Forster R; Bode G; Ellegaard L; van der Laan JW;
J Pharmacol Toxicol Methods; 2010; 62(3):158-9. PubMed ID: 20685395
[TBL] [Abstract][Full Text] [Related]
4. The minipig as nonrodent species in toxicology--where are we now?
Ganderup NC; Harvey W; Mortensen JT; Harrouk W
Int J Toxicol; 2012; 31(6):507-28. PubMed ID: 23134714
[TBL] [Abstract][Full Text] [Related]
5. The utility of the minipig as an animal model in regulatory toxicology.
Bode G; Clausing P; Gervais F; Loegsted J; Luft J; Nogues V; Sims J;
J Pharmacol Toxicol Methods; 2010; 62(3):196-220. PubMed ID: 20685310
[TBL] [Abstract][Full Text] [Related]
6. Ethical implications of using the minipig in regulatory toxicology studies.
Webster J; Bollen P; Grimm H; Jennings M;
J Pharmacol Toxicol Methods; 2010; 62(3):160-6. PubMed ID: 20566379
[TBL] [Abstract][Full Text] [Related]
7. Welfare of the minipig with special reference to use in regulatory toxicology studies.
Ellegaard L; Cunningham A; Edwards S; Grand N; Nevalainen T; Prescott M; Schuurman T;
J Pharmacol Toxicol Methods; 2010; 62(3):167-83. PubMed ID: 20621655
[TBL] [Abstract][Full Text] [Related]
8. The minipig in toxicology.
Svendsen O
Exp Toxicol Pathol; 2006 Jul; 57(5-6):335-9. PubMed ID: 16725317
[TBL] [Abstract][Full Text] [Related]
9. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
10. The RETHINK project: impact of toxicity testing in the minipig as an alternative approach in regulatory toxicity testing.
Curtis MJ
J Pharmacol Toxicol Methods; 2010; 62(3):157. PubMed ID: 20692353
[No Abstract] [Full Text] [Related]
11. Swine as models in biomedical research and toxicology testing.
Swindle MM; Makin A; Herron AJ; Clubb FJ; Frazier KS
Vet Pathol; 2012 Mar; 49(2):344-56. PubMed ID: 21441112
[TBL] [Abstract][Full Text] [Related]
12. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
Box RJ; Spielmann H
Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
[TBL] [Abstract][Full Text] [Related]
13. Comparison of minipig, dog, monkey and human drug metabolism and disposition.
Dalgaard L
J Pharmacol Toxicol Methods; 2015; 74():80-92. PubMed ID: 25545337
[TBL] [Abstract][Full Text] [Related]
14. US regulation of combination products.
Donawa M
Med Device Technol; 2009 Oct; 20(6):22, 24-5. PubMed ID: 20302139
[TBL] [Abstract][Full Text] [Related]
15. Nonclinical evaluation of immunological safety in Göttingen Minipigs: The CONFIRM initiative.
Descotes J; Allais L; Ancian P; Pedersen HD; Friry-Santini C; Iglesias A; Rubic-Schneider T; Skaggs H; Vestbjerg P
Regul Toxicol Pharmacol; 2018 Apr; 94():271-275. PubMed ID: 29481836
[TBL] [Abstract][Full Text] [Related]
16. Combination products regulation at the FDA.
Lauritsen KJ; Nguyen T
Clin Pharmacol Ther; 2009 May; 85(5):468-70. PubMed ID: 19381151
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceuticals and medical devices: medical devices.
Berry MD
Issue Brief Health Policy Track Serv; 2013 Dec; ():1-49. PubMed ID: 24482892
[No Abstract] [Full Text] [Related]
18. The minipig in dermatotoxicology: methods and challenges.
Mahl JA; Vogel BE; Court M; Kolopp M; Roman D; Nogués V
Exp Toxicol Pathol; 2006 Jul; 57(5-6):341-5. PubMed ID: 16713702
[TBL] [Abstract][Full Text] [Related]
19. The Use of Minipigs for Preclinical Safety Assessment by the Pharmaceutical Industry: Results of an IQ DruSafe Minipig Survey.
Colleton C; Brewster D; Chester A; Clarke DO; Heining P; Olaharski A; Graziano M
Toxicol Pathol; 2016 Apr; 44(3):458-66. PubMed ID: 27006130
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceuticals and medical devices: medical devices. Issue brief.
Berry MD
Issue Brief Health Policy Track Serv; 2012 Dec; ():1-35. PubMed ID: 23297445
[No Abstract] [Full Text] [Related]
[Next] [New Search]
